All Product News

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for Aurobindo Receives FDA Approval Ramelteon Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), ROZEREM® Tablets manufactured by Takeda Pharmaceuticals USA Inc. Ramelteon Tablets, are indicated for : Treatment of […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Sevelamer Hydrochloride Tablets 400 mg and 800 mg. Aurobindo Pharma’s Sevelamer Hydrochloride Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), RENAGEL® Tablets manufactured by Genzyme Corporation. Sevelamer Hydrochloride […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Etyqa (Estradiol and Norethindrone Acetate Tablets USP), 0.5 mg/0.1 mg and 1 mg/0.5 mg. Aurobindo Pharma’s Etyqa (Estradiol and Norethindrone Acetate Tablets USP), are an AB-rated generic equivalent to the reference listed […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Rufinamide Tablets USP, 200mg and 400mg. Aurobindo Pharma’s Rufinamide Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Banzel® Tablets, manufactured by Eisai Inc. Rufinamide Tablets, are indicated for: […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Apixaban Tablets, 2.5 mg and 5 mg. Aurobindo Pharma’s Apixaban Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Eliquis Tablets manufactured by Bristol-Myers Squibb Company. Apixaban Tablets are […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for Prednisolone Tablets USP, 5mg. Aurobindo Pharma’s Prednisolone Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Prednisolone (MillipredTM) Tablets USP, manufactured by Watson Laboratories Inc. Prednisolone Tablets, are indicated in the following […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Nitrofurantoin Oral Suspension USP, 25 mg/5 mL. Aurobindo Pharma’s Nitrofurantoin Oral Suspension, are an AB-rated generic equivalent to the reference listed drug (RLD), Furadantin® Oral Suspension manufactured by Casper Pharma LLC. Nitrofurantoin […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Phenoxybenzamine Hydrochloride Capsules USP, 10 mg. Aurobindo Pharma’s Phenoxybenzamine Hydrochloride Capsules, are an AB-rated generic equivalent to the reference listed drug (RLD), Dibenzyline® Capsules manufactured by Concordia Pharmaceuticals Inc. Phenoxybenzamine Hydrochloride Capsules […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Macitentan Tablets, 10 mg. Aurobindo Pharma’s Macitentan Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), OPSUMIT® Tablets manufactured by Actelion Pharmaceuticals US, Inc. Macitentan Tablets are indicated for: […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Cevimeline Hydrochloride Capsules, 30 mg. Aurobindo Pharma’s Cevimeline Hydrochloride Capsules, are an AB-rated generic equivalent to the reference listed drug (RLD), Evoxac® Capsules manufactured by Cosette Pharmaceuticals, Inc. Cevimeline Hydrochloride Capsules are […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Roflumilast Tablets, 500 mcg. Aurobindo Pharma’s Roflumilast Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), DALIRESP® Tablets manufactured by Astrazeneca Pharmaceuticals LP. Roflumilast Tablets are indicated as: A […]

Aurobindo Receives FDA Approval for Prednisolone Tablets USP, 5mg Aurobindo Receives FDA Approval for Prednisolone Tablets USP, 5mg East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Prazosin Hydrochloride Capsules USP, 1mg, 2mg and 5mg. Aurobindo Pharma’s Prazosin Hydrochloride Capsules, are an AB-rated generic equivalent to the reference listed […]